Valproic Acid Antibody (801): sc-58066

Valproic Acid Antibody (801) is a mouse monoclonal IgG1 antibody that detects Valproic Acid protein of non-species reactive by enzyme-linked immunosorbent assay (ELISA). Anti-Valproic Acid antibody (801) is available as a non-conjugated format, specifically designed to facilitate research into the multifaceted roles of Valproic Acid in neurological conditions. Valproic Acid, a fatty acid, serves as an anticonvulsant and mood-stabilizing agent, primarily utilized in the treatment of epilepsy and bipolar disorder, while also being effective for migraine headaches and schizophrenia. Valproic Acid plays a crucial role in modulating neurotransmission, particularly by negatively impacting the inhibitory function of the neurotransmitter gamma-Aminobutyric acid (GABA). This modulation is significant as Valproic Acid can lead to increased GABA levels in the brain, which is essential for maintaining neuronal excitability and preventing seizures. Additionally, Valproic Acid acts as an inhibitor of histone deacetylase 1 (HDAC1), linking Valproic Acid to neuroprotective strategies in HIV therapy. With a molecular weight of 144.211 g/mol and a half-life of 9-16 hours, Valproic Acid is primarily metabolized in the liver to its glucuronide conjugate, making Valproic Acid an important subject of study for understanding pharmacokinetics and therapeutic effects. Common side effects associated with Valproic Acid include dyspepsia and weight gain, highlighting the need for careful monitoring during treatment.